Androgen-dependent regulation of human MUC1 mucin expression.

[1]  B. Yin,et al.  Molecular Cloning of the CA125 Ovarian Cancer Antigen , 2001, The Journal of Biological Chemistry.

[2]  G. Stamp,et al.  Human MUC1 mucin: a potent glandular morphogen , 2001, The Journal of pathology.

[3]  J. White,et al.  MUC 1: a genetic susceptibility to infertility? , 2001, The Lancet.

[4]  S. Gendler,et al.  Transgenic MUC1 Interacts with Epidermal Growth Factor Receptor and Correlates with Mitogen-activated Protein Kinase Activation in the Mouse Mammary Gland* , 2001, The Journal of Biological Chemistry.

[5]  C. Longcope,et al.  Sources of elevated serum androgens in postmenopausal women who develop breast cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  Marcos Meseguer,et al.  Human Endometrial Mucin MUC1 Is Up-Regulated by Progesterone and Down-Regulated In Vitro by the Human Blastocyst1 , 2001, Biology of reproduction.

[7]  E. Lalani,et al.  The endometrium and embryo implantation , 2000, BMJ : British Medical Journal.

[8]  G. Stamp,et al.  Phenotypic and genotypic characterization of commonly used human prostatic cell lines , 2000, BJU international.

[9]  S. Müller,et al.  MUC1: the polymorphic appearance of a human mucin. , 2000, Glycobiology.

[10]  F. Orio,et al.  A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects , 2000, Molecular and Cellular Endocrinology.

[11]  I. Fentiman,et al.  Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey , 2000, British Journal of Cancer.

[12]  D. Carson,et al.  Mammalian reproductive tract mucins. , 1999, Human reproduction update.

[13]  N. Smorodinsky,et al.  The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein. , 1999, Cancer research.

[14]  H. Egami,et al.  Prognostic values of MUC-1 molecule expressing cytokine receptor-like epitope and DF3 in patients with gastric carcinoma. , 1999, International journal of oncology.

[15]  T. Mitsudomi,et al.  MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence. , 1999, The Annals of thoracic surgery.

[16]  M. Sternberg,et al.  Crystal structure at 1.95 A resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition. , 1998, Journal of molecular biology.

[17]  J. Hugh,et al.  MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats. , 1998, Cancer research.

[18]  T. Irimura,et al.  Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  A. Murray,et al.  Evaluation of Pepscan analyses for epitope mapping of anti-MUC1 monoclonal antibodies--a comparative study and review of five antibodies. , 1998, Anticancer Research.

[20]  N. Kohno,et al.  Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines. , 1998, Cancer research.

[21]  T. Li,et al.  Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. , 1998, Fertility and sterility.

[22]  M. McGuckin,et al.  Progesterone stimulates production and secretion of MUC1 epithelial mucin in steroid-responsive breast cancer cell lines. , 1998, International journal of oncology.

[23]  G. Prins,et al.  Expression of epidermal growth factor and androgen receptors in ovarian cancer. , 1997, Gynecologic oncology.

[24]  B. Chilton,et al.  Molecular cloning and hormone-dependent expression of rabbit Muc1 in the cervix and uterus. , 1997, Biology of reproduction.

[25]  D. Kufe,et al.  Interaction of the DF3/MUC1 Breast Carcinoma-associated Antigen and β-Catenin in Cell Adhesion* , 1997, The Journal of Biological Chemistry.

[26]  C. Lombardo,et al.  Structure, Function and Gene Expression of Epithelial Mucins , 1997, Tumori.

[27]  J. Gribben,et al.  Breast cancer–associated antigen, DF3/MUC1, induces apoptosis of activated human T cells , 1996, Nature Medicine.

[28]  D. Horsfall,et al.  Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer. , 1996, British Journal of Cancer.

[29]  N. Peat,et al.  Two GC Boxes (Sp1 Sites) Are Involved in Regulation of the Activity of the Epithelium-specific MUC1 Promoter* , 1996, The Journal of Biological Chemistry.

[30]  J. Wesseling,et al.  A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. , 1996, Molecular biology of the cell.

[31]  E. Lane,et al.  A keratin antibody recognizing a heterotypic complex: epitope mapping to complementary locations on both components of the complex. , 1996, Experimental cell research.

[32]  K. Schulz,et al.  Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[33]  A. Varki,et al.  Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. , 1995, Cancer research.

[34]  S. Dey,et al.  Expression and steroid hormonal control of Muc-1 in the mouse uterus. , 1995, Endocrinology.

[35]  D. Horsfall,et al.  Androgens induce divergent proliferative responses in human breast cancer cell lines , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[36]  Walsh,et al.  Prognostic significance of MUC1 epithelial mucin expression in breast cancer. , 1995, Human pathology.

[37]  A. Sonnenberg,et al.  Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components , 1995, The Journal of cell biology.

[38]  M. Takeichi,et al.  p60v‐src causes tyrosine phosphorylation and inactivation of the N‐cadherin‐catenin cell adhesion system. , 1993, The EMBO journal.

[39]  M. Price,et al.  Immune recognition of linear epitopes in peptide fragments of epithelial mucins. , 1991, Immunology.

[40]  J. Taylor‐Papadimitriou,et al.  Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. , 1987, Cancer research.

[41]  W. Bodmer,et al.  Monoclonal antibodies to epithelium‐specific components of the human milk fat globule membrane: Production and reaction with cells in culture , 1981, International journal of cancer.

[42]  P. Duca,et al.  Urinary testosterone as a marker of risk of recurrence in operable breast cancer , 2004, Breast Cancer Research and Treatment.

[43]  A. Sonnenberg,et al.  Episialin ( MUC 1 ) Overexpression Inhibits Integrin-mediated Cell Adhesion to Extracellular Matrix Components , 2002 .

[44]  J. Nightingale.  Investigation of androgen receptor gene transfection into human prostate cancer cells : effects on cellular growth, apoptosis and adhesion. , 2000 .

[45]  M. Urashima,et al.  Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone. , 1999, Blood.

[46]  Levine,et al.  MUC1 Expression in Prostate Carcinoma: Correlation with Grade and Stage. , 1999, Molecular urology.

[47]  S. Slayden.  Risks of Menopausal Androgen Supplementation , 1998, Seminars in reproductive endocrinology.

[48]  R. Sutherland,et al.  MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression. , 1994, European journal of cancer.

[49]  R. Matusik,et al.  Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. , 1993, Molecular endocrinology.

[50]  B. Thomas,et al.  Hormones are ambiguous risk factors for breast cancer. , 1989, Acta oncologica.

[51]  E. Crawford.  Combined androgen blockade , 1989, Urology.